BrainStorm

March 31, 2014

How Close Are We to an Approved Treatment? - Bernard Munos

Thumbnail

How Close Are We to an Approved Treatment? - Bernard Munos

About This Episode

A discussion with Bernard Munos, Founder of InnoThink, and named one of the 25 most influential people in biopharma by FiercePharma.  He discussed his analysis of the drug pipeline, the status of drugs in it, as well as his recommendations for how we can organize research more effectively and lower the cost of innovation and reduce the risk of failure so that we can get to a cure faster and at lower cost.

This call was made possible by the generous support of the Zickler Family Foundation.

BrainStorm Feed

84
April 15, 2025 | 19:43

Greg O'Brien – Advocating for Scientific Research for Alzheimer’s

Journalist and author Greg O'Brien, diagnosed with early-onset Alzheimer's over a decade ago, shares with BrainStorm host Meryl his determination t

LISTEN NOW
83
April 1, 2025 | 12:23

Doreen Monks – The Emotional Journey of Alzheimer’s and Dementia (part 2)

In this episode of BrainStorm, host Meryl Comer continues explore the challenges of dementia diagnosis in her interview with Doreen Monks, a former

LISTEN NOW
82
March 18, 2025 | 16:54

Doreen Monks – The Emotional Journey of Alzheimer’s and Dementia (part 1)

What if your life and career were upended with a diagnosis of Alzheimer’s only to learn eight years later that the diagnosis was wrong?  In th

LISTEN NOW